US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Durisan Antimicrobial Solutions

Reason CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Sanit Technologies, LLC dba Durisan D-0658-2021
Class II · Moderate risk Terminated

0.9% SODIUM CHLORIDE Irrigation

Reason Presence of particulate matter.one confirmed customer report of particulate matter within two semi-rigid bottles identified prior to use

ICU Medical Inc NDC 0990-7138-09 D-0313-2021
Class II · Moderate risk Terminated

Gabapentin Oral Solution

Reason Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing

Akorn, Inc. D-0301-2021
Class II · Moderate risk Terminated

Nortriptyline HCL capsules

Reason cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.

Direct Rx D-0300-2021
Class II · Moderate risk Terminated

Progesterone Capsules

Reason Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.

Dr. Reddy's Laboratories, Inc. NDC 43598-350-01 D-0292-2021
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel.

Noven Pharmaceuticals Inc NDC 68968-5555-3 D-0296-2021
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel.

Noven Pharmaceuticals Inc NDC 68968-5554-3 D-0295-2021
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel.

Noven Pharmaceuticals Inc NDC 68968-5553-3 D-0294-2021
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel.

Noven Pharmaceuticals Inc NDC 68968-5552-3 D-0293-2021
Class II · Moderate risk Terminated

Fludeoxyglucose F 18 Injection

Reason Lack of Assurance of Sterility

The General Hospital Corporation NDC 76318-334-50 D-0288-2021
Class II · Moderate risk Terminated

Imatinib Mesylate Tablets 100mg

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-344-90 D-0287-2021
Class II · Moderate risk Terminated

Metoclopramide Injection USP

Reason Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Teva Pharmaceuticals USA NDC 0703-4502-01 D-0297-2021
Class II · Moderate risk Terminated

Leucovorin Calcium for Injection

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-5145-01 D-0285-2021
Class II · Moderate risk Terminated

MethyIPREDNISolone Acetate Injectable Suspension USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-0063-01 D-0284-2021
Class II · Moderate risk Terminated

MethyIPREDNISolone Acetate Injectable Suspension USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-0043-01 D-0283-2021
Class II · Moderate risk Terminated

MethyIPREDNISolone Acetate Injectable Suspension USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-0045-01 D-0282-2021
Class II · Moderate risk Terminated

MethyIPREDNISolone Acetate Injectable Suspension USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-0051-01 D-0281-2021
Class II · Moderate risk Terminated

Epoprostenol Sodium for Injection

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-1995-01 D-0280-2021
Class II · Moderate risk Terminated

Vecuronium Bromide for Injection

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-2914-01 D-0279-2021
Class II · Moderate risk Terminated

Toposar

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-5657-01 D-0278-2021
Class II · Moderate risk Terminated

Metoclopramide Injection USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-4502-01 D-0277-2021
Class II · Moderate risk Terminated

Leucovorin Calcium for Injection

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-5140-01 D-0276-2021
Class II · Moderate risk Terminated

MethyIPREDNISolone Acetate Injectable Suspension USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-0031-01 D-0275-2021
Class II · Moderate risk Terminated

Epoprostenol Sodium for Injection

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-1985-01 D-0274-2021